Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:49 AM
Ignite Modification Date:
2025-12-25 @ 2:49 AM
NCT ID:
NCT03203733
Eligibility Criteria:
Inclusion Criteria:
* Patients between 16 and 99 years of age diagnosed with lymphoma or myeloma
* Able to communicate in Swedish
* Treated with bis-chloroethylnitrosourea, etoposide, cytarabine, and cyclophosphamide(BEAC) or bis-chloroethylnitrosourea, etoposide, cytarabine, and melphalan (BEAM) (lymphoma diagnosis), melphalan (myeloma diagnosis), before stem cell transplantation (SCT)
Exclusion Criteria:
* Patients who do not understand oral and written information in Swedish.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT03203733
Study Brief:
Protocol Section:
NCT03203733